Building a Community-based Network to Promote Smoking Cessation

The University of Hong Kong457 enrolled

Overview

This study describes the development of a community-based network to promote smoking cessation among female smokers in Hong Kong.

There is growing concern about the use of tobacco among women in Hong Kong. Nevertheless, nearly all of them reported that they had not attended smoking cessation services provided by the government and other organizations, of which only 6.7% indicated that they would like to attend, demonstrating the need for population-based smoking cessation interventions targeting female smokers in Hong Kong. In response to the increased number of female smokers and their low usage rates of smoking cessation services, the first smoking cessation hotline for female smokers in Hong Kong was established in 2006 by the University of Hong Kong. The aim of this study was to describe the development of a community-based network to promote the smoking cessation hotline among female smokers in Hong Kong.

Study Type

INTERVENTIONAL

Allocation

Purpose

HEALTH_SERVICES_RESEARCH

Masking

NONE

Enrollment

457

Conditions

Smoking

Interventions

A brief interventionBEHAVIORAL

The content of the intervention includes: (1) asking about tobacco use; (2) advising cessation; (3) assessing willingness to quit; (4) assisting in the attempt to quit; and (5) arranging follow-up.

Eligibility

Sex: FEMALE

Medical Language ↔ Plain English

Inclusion Criteria: * Female Hong Kong Chinese current smokers * Aged 15 years or above * Able to speak and understand Cantonese * Willing to receive face-to-face or telephone counseling Exclusion Criteria: * Those who were participating in other smoking cessation programs or services

Locations (1)

The University of Hong Kong

Hong Kong SAR, China

Outcomes

Primary Outcomes

self-reported 7-day point prevalence of abstinence

Time frame: 6 months

Secondary Outcomes

self-reported reduction of ≥ 50% in cigarette consumption

Time frame: 6 months

Levels of self-efficacy at baseline

Time frame: baseline

Levels of self-efficacy at six months

Time frame: six months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.